Avella of Deer Valley, Inc. Store 38 product recalled over sterility concerns
- Recall date
- June 12, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Avella of Deer Valley, Inc. Store 38 recalls 0.2% ROPivacaine, (Ropivacaine HCL PF, USP 500mg, 0.9% Sodium Chloride, USP QS 250 mL). Volume 250 mL. Single dose Cass…
- Recall number
- D-0942-2018
- FDA classification
- Class II
- Brand / firm
- Avella of Deer Valley, Inc. Store 38
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Lack of Assurance of Sterility: Potential leakage of bags.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
0.2% ROPivacaine, (Ropivacaine HCL PF, USP 500mg, 0.9% Sodium Chloride, USP QS 250 mL). Volume 250 mL. Single dose Cassette. For: Parkland Memorial Hospital. By: Advanced Pharma, 9225 Kirby Dr. Houston, TX 77054. Parkland Memorial Hospital NDC 15082-002-87
Get recall alerts
Free email alert whenever Avella of Deer Valley, Inc. Store 38 has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Avella of Deer Valley, Inc. Store 38